Related Experiment Video
Updated: May 28, 2026
09:30
Microbial Control and Monitoring Strategies for Cleanroom Environments and Cellular Therapies
Published on: March 17, 2023
Japanese pharmaceutical and regulatory environment
Ryoichi Nagata1, Jean-David Rafizadeh-Kabe
1CEO and Chairman, SNBL Ltd, Kagoshima, Japan (Ryoichi Nagata); Medical Advisor, SNBL Ltd, Baltimore, Md, USA (Jean-David Rafizadeh-Kabe).
Dialogues in Clinical Neuroscience
|October 29, 2011
Summary
Japan
Area of Science:
- Pharmaceutical Science
- Regulatory Affairs
- Clinical Research
Background:
- Significant regulatory reforms in Japan since 1997 have reshaped new medicine development.
- The Japanese regulatory authority has undergone substantial transformation.
- Clinical trials now adhere to global standards.
Purpose of the Study:
- To analyze the impact of regulatory changes in Japan on drug development.
- To highlight the shift towards international harmonization in clinical data acceptance.
- To discuss the future trajectory of pharmaceutical development and regulatory submissions.
Main Methods:
- Review of regulatory changes in Japan post-1997.
- Analysis of the adoption of international clinical trial guidelines.
- Examination of the bridging process for international data acceptance.
Main Results:
- Japanese regulatory landscape has been significantly altered.
- Clinical trial data generated in Japan is increasingly recognized globally.
- A bridging process facilitates temporary acceptance of regional data.
Conclusions:
- The future of drug development necessitates global collaboration.
- Multinational clinical trials are essential for efficient drug approval.
- Simultaneous submissions to major regulatory bodies will become standard practice.
Related Concept Videos
01:25Drug Regulation
Drug regulation encompasses the management of drug usage by evaluating its safety and efficacy through assessments conducted by regulatory authorities. Regrettably, the history of drug regulation is marred by several catastrophic events. One such incident is the Elixir Sulfanilamide tragedy, in which the toxic compound diethyl glycol was included in a sweet-tasting medication, leading to numerous fatalities. This event prompted the enactment of the Food, Drug, and Cosmetic Act in 1938. Under...
01:03Drug Control Governance: Regulatory Bodies and Their Impact
Drug control governance involves the oversight and regulation of pharmaceuticals to ensure their safety and efficacy while preventing illegal drug use and trafficking. Regulatory bodies, including the US Food and Drug Administration (FDA) and the European Union's European Medicines Agency (EMA), play a central role in this process. These agencies evaluate the safety and efficacy of drugs before they can be marketed. They fund clinical trials and assess the benefits and risks associated with a...
01:15Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
PK–PD modeling has significantly influenced FDA regulatory decisions, particularly drug approval, dosage optimization, and labeling. These models integrate pharmacokinetics (PK) and pharmacodynamics (PD) to predict drug behavior and effects, aiding in optimizing dosing regimens and enhancing the probability of clinical trial success.One notable example is Nesiritide (Natrecor®), a recombinant human brain natriuretic peptide for treating acute decompensated congestive heart failure (CHF).
01:28Global Regulatory Systems
Global regulatory systems in bacteria enable rapid and coordinated responses to environmental changes by integrating sensory inputs with gene expression, ensuring efficient adaptation to fluctuating conditions. Key global regulatory mechanisms include regulons, two-component systems, sigma factors, and secondary messengers.Regulons and Global RegulatorsA regulon is a collection of genes and operons controlled by a common global regulator. These regulators enable bacteria to prioritize resource...
01:28Drug Products: Biologics, Biosimilars and Interchangeables
Biologics, derived from living sources such as humans, animals, or microorganisms, represent a significant category of pharmaceuticals. These complex molecules, developed through advanced biotechnological methods or purified from natural sources, include essential medical treatments like insulin and growth hormones. The complexity of biologics arises from their large molecular structures and the intricate processes required for their production, making them distinct from conventional...
01:19Pharmacovigilance
Post-marketing surveillance is a critical component of pharmaceutical regulation, often uncovering unanticipated adverse drug reactions (ADRs) once a drug is widely used over an extended period.
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...
This process, termed pharmacovigilance, aims to detect, evaluate, and minimize harmful effects related to medication use. The data collection for pharmacovigilance depends on spontaneous reporting systems, where healthcare professionals or patients voluntarily report suspected ADRs.
In some cases, there...